miR-641 inhibits breast cancer cell migration and enhances apoptosis, which is reversed by PI3K inhibitor, suggesting miR-641-induced apoptosis through the targeting of the NUCKS1/PI3K/AKT axis [45]. Here, AKT1 is linked to breast carcinoma.